Rahimi Siavash, Akaev Iolia, Repanos Costa, Brennan Peter A, Dubois Jean Daniel
Pathology Centre-Histopathology, Queen Alexandra Hospital, Southwick Hill Road, Cosham, Portsmouth, PO6 3LY, UK.
School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, UK.
Head Neck Pathol. 2017 Jun;11(2):186-191. doi: 10.1007/s12105-016-0759-9. Epub 2016 Oct 17.
Primary lingual intestinal-type adenocarcinomas are extremely rare with only a few cases described. A case with immunohistochemical expression of Androgen Receptor (AR) which was treated solely by chemo-radiotherapy is reported herein. A 54-year-old male was referred with symptoms of fullness in his tongue. Clinical examination showed an asymmetry of the tongue with a hard mass palpable within the middle of the tongue. Biopsy showed intestinal-type adenocarcinoma. The tumour showed positive staining with cytokeratin 7, cytokeratin 20, CDX2, AR, β-catenin and was mismatch repair proteins (MMR) proficient. The molecular analysis did not show mutations in the KRAS, NRAS, BRAF and PIK3CA genes. The patient was treated with radiochemotherapy and is in remission 3.5 years after the diagnosis. This is the first case of intestinal-type tongue adenocarcinoma which showed AR expression and was treated solely with radical chemoradiotherapy.
原发性舌肠型腺癌极为罕见,仅有少数病例报道。本文报告一例仅接受放化疗治疗且雄激素受体(AR)免疫组化呈阳性表达的病例。一名54岁男性因舌部胀满症状前来就诊。临床检查发现舌部不对称,舌中部可触及一硬肿块。活检显示为肠型腺癌。肿瘤细胞角蛋白7、细胞角蛋白20、CDX2、AR、β-连环蛋白染色呈阳性,错配修复蛋白(MMR)功能正常。分子分析未显示KRAS、NRAS、BRAF和PIK3CA基因存在突变。该患者接受了放化疗,诊断后3.5年病情缓解。这是首例显示AR表达且仅接受根治性放化疗的舌肠型腺癌病例。